KalVista Pharmaceuticals (KALV) Leases (2019 - 2024)
Historic Leases for KalVista Pharmaceuticals (KALV) over the last 5 years, with Q4 2024 value amounting to $5.6 million.
- KalVista Pharmaceuticals' Leases changed N/A to $5.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $5.6 million, marking a year-over-year change of. This contributed to the annual value of $6.9 million for FY2024, which is N/A changed from last year.
- Latest data reveals that KalVista Pharmaceuticals reported Leases of $5.6 million as of Q4 2024.
- In the past 5 years, KalVista Pharmaceuticals' Leases ranged from a high of $7.6 million in Q3 2023 and a low of $1.3 million during Q4 2020
- For the 4-year period, KalVista Pharmaceuticals' Leases averaged around $4.5 million, with its median value being $5.7 million (2024).
- As far as peak fluctuations go, KalVista Pharmaceuticals' Leases surged by 21920.79% in 2020, and later plummeted by 2261.26% in 2024.
- KalVista Pharmaceuticals' Leases (Quarter) stood at $1.3 million in 2020, then grew by 26.67% to $1.7 million in 2021, then skyrocketed by 341.5% to $7.3 million in 2023, then dropped by 23.62% to $5.6 million in 2024.
- Its Leases was $5.6 million in Q4 2024, compared to $5.9 million in Q4 2024 and $5.9 million in Q3 2024.